SHPH
NASDAQShuttle Pharmaceuticals Holdings Inc.
News25/Ratings0
News · 26 weeks290%
2025-11-022026-04-26
Mix1590d
- SEC Filings13(87%)
- Offering2(13%)
Latest news
25 items- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRShuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin MinerThe combination and related financing is expected to result in the largest publicly listed Dogecoin mining company based on percentage of the global hashrateGaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ:SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. United Dogecoin will be merged into a wholly owned subsidiary of Shuttle. The merger is supported by a $11 million concurrent Private Investment in Public Equity ("PIPE") financing expected to close on May 4, 2026. United Dogecoin's competitive adv
- SECSEC Form DEF 14A filed by Shuttle Pharmaceuticals Holdings Inc.DEF 14A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form PRE 14A filed by Shuttle Pharmaceuticals Holdings Inc.PRE 14A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 10-K filed by Shuttle Pharmaceuticals Holdings Inc.10-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRE.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public OfferingNEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. ("E.F. Hutton"), a leading investment banking and financial advisory firm, today announced that it acted as the exclusive placement agent in connection with a $3.5 million public offering by Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharmaceuticals" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular discovery and early-stage drug development. Shuttle Pharmaceuticals entered into a securities purchase agreement with investors for the issuance and sale of 2,238,800 shares of common stock and pre-funded warrants to purchase 4,761,200 shares of common s
- SECSEC Form 8-K filed by Shuttle Pharmaceuticals Holdings Inc.8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 424B3 filed by Shuttle Pharmaceuticals Holdings Inc.424B3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form EFFECT filed by Shuttle Pharmaceuticals Holdings Inc.EFFECT - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECAmendment: SEC Form S-1/A filed by Shuttle Pharmaceuticals Holdings Inc.S-1/A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form S-1 filed by Shuttle Pharmaceuticals Holdings Inc.S-1 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 424B3 filed by Shuttle Pharmaceuticals Holdings Inc.424B3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form EFFECT filed by Shuttle Pharmaceuticals Holdings Inc.EFFECT - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- INSIDERSEC Form 3 filed by new insider Liang Yuying3 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Issuer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECAmendment: SEC Form S-1/A filed by Shuttle Pharmaceuticals Holdings Inc.S-1/A - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECShuttle Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- PRShuttle Pharmaceuticals Acquires AI Health PlatformRockville, Maryland--(Newsfile Corp. - November 21, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle" or the "Company") today announced that it has closed the acquisition of the assets and liabilities of 1542770 B.C. Ltd. d/b/a Molecule.ai ("Molecule"), a Canadian artificial intelligence company specializing in molecular discovery and drug development technologies.Under the terms of the agreement, 1563868 B.C. Ltd., a wholly owned subsidiary of Shuttle, acquired substantially all of Molecule's assets and liabilities for a total purchase price of $8 million, payable in a combination of cash and shares of Shuttle common stock, plus an additional contingent $2 million, pay
- SECSEC Form S-1 filed by Shuttle Pharmaceuticals Holdings Inc.S-1 - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
- SECSEC Form 8-K filed by Shuttle Pharmaceuticals Holdings Inc.8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)
SHPH FAQ
5 questionsWhere does SHPH stock trade?
Shuttle Pharmaceuticals Holdings Inc. (SHPH) is listed on NASDAQ.What sector and industry is SHPH in?
Shuttle Pharmaceuticals Holdings Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Shuttle Pharmaceuticals Holdings Inc. go public?
Shuttle Pharmaceuticals Holdings Inc. (SHPH) completed its IPO in 2022.What companies are similar to SHPH?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), NVS (Novartis AG). Compare SHPH side-by-side with any of them on Quantisnow.How can I track SHPH on Quantisnow?
Quantisnow aggregates Shuttle Pharmaceuticals Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SHPH to receive live email and push alerts on every new disclosure.